![Claire Xu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 180 504 $ al 30/09/2026
Claire Xu is currently Senior VP, Head-Research & Development at NovaBridge Biosciences since 2024.
Education history includes an undergraduate degree from Zhongshan School of Medicine in 2008 and a doctorate from The Indiana University School of Medicine in 2013.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NOVABRIDGE BIOSCIENCES 0,16 % | 31/08/2026 | 304.201 ( 0,16 % ) | 180 504 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NOVABRIDGE BIOSCIENCES | Director Técnico/Científico/I+D | 01/04/2024 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Zhongshan School of Medicine
 Zhongshan School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Indiana University School of Medicine
 The Indiana University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
I-Mab
 I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
